FDA Panel To Review Atritech’s Watchman Stroke-Prevention Device

FDA's Circulatory System Devices panel will meet April 23 to review a PMA for Atritech's Watchman minimally invasive stroke-prevention device for patients with atrial fibrillation, according to the company

More from Archive

More from Medtech Insight